61 – 70 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
(
- Contribution to journal › Article
- 2008
-
Mark
Gene expression profiling for the identification of G-protein coupled receptors in human platelets
(
- Contribution to journal › Article
- 2007
-
Mark
Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers
(
- Contribution to journal › Article
-
Mark
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
(
- Contribution to journal › Article
-
Mark
The APC-PCI complex concentration predicts outcome of aortic surgery.
(
- Contribution to journal › Article
-
Mark
Von Willebrand: The scientist, the disease, the factor, and the treatment
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Erik von Willebrand.
(
- Contribution to journal › Article
-
Mark
Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.
(
- Contribution to journal › Article
- 2006
-
Mark
The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.
(
- Contribution to journal › Article
-
Mark
The need for prophylaxis in von Willebrand's disease and other coagulation disorders
(
- Contribution to journal › Debate/Note/Editorial